Stock Region Penny Picks
Stock Region Penny Picks Watchlist Newsletter - Wednesday, December 4th, 2024.
Stock Region Penny Picks Watchlist Newsletter - Wednesday, December 4th, 2024
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: This newsletter is for informational purposes only and should not be considered financial advice. Always conduct your own research or consult with a financial advisor before making investment decisions.
Today's Market Highlights:
$CANF
Can-Fite BioPharma reported a groundbreaking milestone. A patient with advanced liver cancer achieved an 8-year survival and a complete cure using their Namodenoson drug.
$SRM
SRM Entertainment saw a remarkable surge in Amazon sales, climbing over 400% in just three months. This boost has significantly strengthened the company's financial performance.
$THTX
Theratechnologies entered an exclusive licensing deal with Ionis Pharmaceuticals to bring Olezarsen and Donidalorsen to the Canadian market.
$WINT
Windtree Therapeutics teamed up with New Growth Advisors. This partnership aims to capitalize on their promising Phase 2 results for Istaroxime in treating cardiogenic shock. They’re eyeing a potential strategic transaction.
$SPAI
Safe Pro AI hit a major milestone with their SpotlightAI™ technology. It has detected over 16,500 lethal explosives in Ukraine, showcasing the effectiveness of AI-powered drone imagery solutions.
$SGBX
Safe & Green Holdings secured two fresh contracts for modular construction projects, further expanding their portfolio.
$FGL
Founder Group achieved a significant win with a conditional letter of award for a 100MW solar farm project in Malaysia, worth approximately $68 million.
$APVO
Aptevo Therapeutics introduced APVO442, a bispecific antibody for prostate cancer. It features targeted tumor precision with fewer side effects, advancing the treatment landscape.
$CETX
Cemtrex announced their plans to fully acquire Vicon Industries, marking another step in their growth strategy.
$SONN
Sonnet BioTherapeutics revealed the mechanism of action for SON-1010, their IL-12 fusion protein. Their study showcases its innovative albumin-binding approach.
$AMZN
Amazon’s AWS re:Invent conference began earlier this week and will conclude on Friday. Be on the lookout for potential updates and announcements.
$PRFX
PainReform (PRFX) announced they have regained compliance with Nasdaq’s minimum bid price requirement, ensuring continued listing on the exchange.
$MIGI
Mawson Infrastructure Group is facing an involuntary Chapter 11 bankruptcy filing by certain Australian creditors. However, no jurisdiction has been assumed by the court at this time, and the company has not been formally served.
Disclaimer: The information provided in this newsletter is not a recommendation to buy, sell, or hold any of the mentioned securities. Market conditions change rapidly, and past performance is not indicative of future results. Always consult with a professional before making financial decisions.
We are working endlessly to provide free insights on the stock market every day, and greatly appreciate those who are paid members supporting the development of the Stock Region mobile application. Stock Region offers daily stock and option signals, watchlists, earnings reports, technical and fundamental analysis reports, virtual meetings, learning opportunities, analyst upgrades and downgrades, catalyst reports, in-person events, and access to our private network of investors for paid members as an addition to being an early investor in Stock Region. We recommend all readers to urgently activate their membership before reaching full member capacity (500) to be eligible for the upcoming revenue distribution program. Memberships now available at https://stockregion.net